Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,510.00
Bid: 12,524.00
Ask: 12,526.00
Change: 118.00 (0.95%)
Spread: 2.00 (0.016%)
Open: 12,468.00
High: 12,556.00
Low: 12,434.00
Prev. Close: 12,392.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

Thu, 25th Apr 2024 09:12

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Amongst individual stocks, Anglo American shares jumped, after it confirmed that it was "reviewing" a takeover bid from its larger Australian rival BHP Group.

The FTSE 100 index opened up 33.81 points, 0.4%, at 8,074.19. The FTSE 250 was down 98.85 points, 0.5%, at 19,620.52, and the AIM All-Share was down 0.60 of a point, 0.1%, at 754.09.

The Cboe UK 100 was up 0.5% at 806.43, the Cboe UK 250 was down 0.5% at 16,979.96, and the Cboe Small Companies was down marginally at 15,317.25.

In European equities on Thursday, the CAC 40 in Paris was down 0.3%, while the DAX 40 in Frankfurt was down 0.1%.

All eyes are on US economic data. Thursday's economic calendar has a gross domestic product reading at 1330 BST.

"A strong GDP reading would suggest that the US economy is sufficiently strong to support corporate earnings, but it could also delay expectations for a Fed rate cut. Conversely, a softer-than-expected GDP figure would likely increase expectations for a rate cut, especially if earnings disappoint due to inflated expectations," said Ipek Ozkardeskaya at Swissquote Bank.

"Overall, I believe that a softer-than-expected GDP would elicit a more positive market reaction, but the risks surrounding GDP lean towards a better-than-expected reading."

After the GDP reading, attention will quickly turn to personal consumption expenditure data, which is the Fed's preferred gauge of inflation.

Friday's US PCE reading is expected to show the annual core PCE inflation measure eased to 2.6% in March from 2.8% in February.

The pound was quoted at USD1.2491 early on Thursday in London, higher compared to USD1.2432 at the equities close on Wednesday. The euro stood at USD1.0714, higher against USD1.0687. Against the yen, the dollar was trading at JPY155.65, up compared to JPY155.06.

In the FTSE 100, Anglo American took the spotlight, jumped 13%.

The miner confirmed that it was "reviewing" a takeover bid from its larger Australian rival BHP Group, in what would rank as one of the sector's biggest deals in years.

Anglo American did not disclose the price of the "unsolicited" offer, which must be sewn up before a deadline of May 22.

However, BHP subsequently said the offer values Anglo American's share capital at GBP31.1 billion.

Australian-based BHP has a market value of around USD148 billion, while London-based Anglo American has a market value of about USD36 billion.

AstraZeneca rose 5.3%.

The pharmaceutical firm reported that revenue rose to USD12.68 billion in the first quarter of 2024, up 17% from USD10.88 billion a year earlier. Pretax profit jumped to USD2.80 billion from USD2.62 billion.

On the back of the results, Astra upped its dividend to USD3.10 from USD2.90.

In the FTSE 250, Inchcape edged 5.3% higher.

The London-based automotive distributor said revenue rose 5% on a reported basis to GBP2.3 billion in the first quarter of 2024. On an organic basis, the figure edged up 6% and at constant FX rates was 11% higher.

"Our positive start to 2024 reflects the underlying quality of our business and we have confidence in, and we have reiterated, our outlook for the year," said Chief Executive Duncan Tait.

On the other hand, WH Smith lost 7.5%.

The London-based retailer, which operates on UK high streets and travel locations like airports and train stations globally, said revenue rose 8% to GBP926 million in the six months ended February 29, from GBP859m a year earlier.

Pretax profit, however, fell to GBP28 million from GBP45 million.

Looking ahead, WH Smith said it is on track to deliver full year results in line with expectations.

CEO Carl Cowling said: "The group is in its strongest ever position as a global travel retailer. We have had a good first half and our businesses are well positioned for the peak summer trading period."

In the US on Wednesday, stocks on Wall Street were muted, with the Dow Jones Industrial Average closing down 0.1%, the S&P 500 rising marginally, and the Nasdaq Composite adding 0.1%.

After the closing bell in New York, Meta Platforms plunged 15% in after-hours trading.

Meta signalled higher-than-expected costs lay ahead as it ploughs more cash into artificial intelligence after reporting another bumper quarter.

The owner of Facebook and Instagram reported a double-digit increase in quarterly revenue, while profit more than doubled year-on-year in the first quarter. However, it increased guidance for full-year total expenses and capital expenditures, and warned that operating losses at Reality Labs would increase "meaningfully".

Alphabet, Intel, and Microsoft are all due to report earnings on Thursday.

In Asia on Thursday, the Nikkei 225 index in Tokyo was down 2.2%. In China, the Shanghai Composite was up 0.3%, while the Hang Seng index in Hong Kong was up 0.4%.

In Sydney, financial markets were closed for Anzac Day.

Brent oil was quoted at USD88.21 a barrel early in London on Thursday, up from USD88.12 late Wednesday.

Gold was quoted at USD2,320.70 an ounce, lower against USD2,329.42.

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.